Dr. Corcoran On Immunotherapy For Microsatellite Stable/Instable Crc

Dr. Corcoran on Immunotherapy for Microsatellite Stable/Instable CRC

Dr. Corcoran on Promising Combination Strategies With Immunotherapy in mCRC

Dr. Corcoran on the Utility of Regorafenib in CRC

Dr. Corcoran on Targeting HER2 Amplification in CRC

Role of Immunotherapy in Microsatellite-Stable R/R mCRC

Dr. Jiang on the Future of Immunotherapy in Microsatellite Stable Colorectal Cancer

Dr. Bendell on the Treatment of Microsatellite Stable Patients With CRC

Ryan Corcoran, MD, explains the need for the MRD test in CRC and whether its ready for prime time

The emerging role of immunotherapy for microsatellite stable colorectal cancer

First-line durvalumab + monalizumab in microsatellite-stable CRC

How can we incorporate checkpoint inhibition in microsatellite stable colorectal cancer?

Dr. McCollum on Immunotherapy in MSS CRC

Emerging Immunotherapy Combinations in MSS CRC

Immunotherapy Options in CRC

Targeted Oncology

Immunotherapy Regimens in dMMR/MSI-High Metastatic CRC

Debate: MSI High Colon Cancer - Immunotherapy

Dr. Bendell on the Next Steps Following Progression on Immunotherapy in MSI-H CRC

Dr. Marshall Discusses Immunotherapy Progress in the Treatment of CRC

Targeted Oncology

Immunotherapy plus TKIs for the treatment of CRC

Dr. Bekaii-Saab on Microsatellite Instability in Colorectal Cancer